|
|
Post by centralcoastinvestor on Mar 3, 2020 9:21:55 GMT -5
|
|
|
|
Post by nylefty on Mar 3, 2020 10:11:26 GMT -5
Some interesting bits: “We know that the company will be here for the long run and we can control our own destiny,” Castagna says, crediting director, corporate communications Naomi Bandison-Johnson as the driving force behind the new brand. MannKind has not hired a replacement for chief marketing officer Garrett Ingram, who left the company in June.
--------------------------------------------------------------
It should be noted that Castagna is not the first CEO to attempt to breathe life into Afrezza. Former chief execs Hakan Edstrom, Duane DeDisto and Pfeffer had their own ideas that ultimately didn’t work.
--------------------------------------------------------------
Look for Afrezza to go global, likely in partnership with another organization or organizations. Similarly, expect MannKind to double down on endocrinology, even as other companies seek to exit the highly competitive space.
“We’ll be one of the mainstays,” Castagna predicts. “We did a landscape assessment and identified three to five new opportunities we think we can win in and start to move forward. We’re just getting started.”
From the March 01, 2020 Issue of MM&M - Medical Marketing and Media |
|
|
|
Post by apidistra on Mar 3, 2020 10:59:56 GMT -5
Some interesting bits: “We know that the company will be here for the long run and we can control our own destiny,” Castagna says, crediting director, corporate communications Naomi Bandison-Johnson as the driving force behind the new brand. MannKind has not hired a replacement for chief marketing officer Garrett Ingram, who left the company in June.
--------------------------------------------------------------
It should be noted that Castagna is not the first CEO to attempt to breathe life into Afrezza. Former chief execs Hakan Edstrom, Duane DeDisto and Pfeffer had their own ideas that ultimately didn’t work.
--------------------------------------------------------------
Look for Afrezza to go global, likely in partnership with another organization or organizations. Similarly, expect MannKind to double down on endocrinology, even as other companies seek to exit the highly competitive space.
“We’ll be one of the mainstays,” Castagna predicts. “We did a landscape assessment and identified three to five new opportunities we think we can win in and start to move forward. We’re just getting started.”
From the March 01, 2020 Issue of MM&M - Medical Marketing and MediaThis is an excellent piece and the first one like it on the company I've ever read. Is it the result of the new marketing strategy? If so, it's the first success I've seen in the PR area, which makes me hopeful for the new marketing campaign. |
|
|
|
Post by rfogel on Mar 3, 2020 13:09:18 GMT -5
I seem to be missing the point of the "rebranding." I mean, what purpose does "new lobby signage and personalized desk drops" serve? Ditto "employee giveaways — tote and jacket"? Is it just to boost employee morale?
And is "humann" supposed to be the "clean, sleek-looking logo that’s really bold"? I really can't find anything on their website that I would call a logo.
|
|
|
|
Post by mango on Mar 3, 2020 13:19:38 GMT -5
Great article! Really enjoyed it thank you! 👍👍
|
|
|
|
Post by nylefty on Mar 3, 2020 14:03:01 GMT -5
I seem to be missing the point of the "rebranding." I mean, what purpose does "new lobby signage and personalized desk drops" serve? Ditto "employee giveaways — tote and jacket"? Is it just to boost employee morale? And is "humann" supposed to be the "clean, sleek-looking logo that’s really bold"? I really can't find anything on their website that I would call a logo. From MannKind's Twitter feed:  |
|
|
|
Post by ktim on Mar 3, 2020 18:30:38 GMT -5
I understand this is all about corporate branding, so this must be taken in that context of who their readers are, but yikes, I wish they hand't used "reboot" in the title. We've had too many resets, reboots, etc. when it comes to Afrezza. The notion of starting aver from scratch with Afrezza marketing (I'm sure not intended) is awful. Duane DeDisto had his own ideas for MNKD that didn't work, whaaaat? Seems like his plan was to take a look at everything and decide to run. (I've always been highly skeptical of the non-compete thing as that is normally always vetted before a high level hire is announced). Maybe any shareholder of three or more years should get a tote and jacket as well... how about boosting our morale. I could then show off my six figure clothing to people... suitable for a red carpet  |
|
|
|
Post by mannmade on Mar 3, 2020 19:22:05 GMT -5
And don't forget Michael Pfeffer...  |
|
|
|
Post by sayhey24 on Mar 3, 2020 19:32:18 GMT -5
Two take aways for me
1. Former chief execs Hakan Edstrom, Duane DeDisto and Pfeffer - I must have missed Duane's drive by tenure.
2. Look for Afrezza to go global, likely in partnership with another organization or organizations. Similarly, expect MannKind to double down on endocrinology, even as other companies seek to exit the highly competitive space. - I have put on my glasses looking for the global partnership
|
|
|
|
Post by ktim on Mar 3, 2020 19:42:38 GMT -5
Two take aways for me 1. Former chief execs Hakan Edstrom, Duane DeDisto and Pfeffer - I must have missed Duane's drive by tenure.
2. Look for Afrezza to go global, likely in partnership with another organization or organizations. Similarly, expect MannKind to double down on endocrinology, even as other companies seek to exit the highly competitive space. - I have put on my glasses looking for the global partnership It's possible he put his car in park, but I don't think he made it into the building. The likelihood of a "global partnership" drops significantly with each new country partnership announced. He are going global, just a piecemeal approach. |
|
|
|
Post by rockstarrick on Mar 3, 2020 21:57:57 GMT -5
I seem to be missing the point of the "rebranding." I mean, what purpose does "new lobby signage and personalized desk drops" serve? Ditto "employee giveaways — tote and jacket"? Is it just to boost employee morale? And is "humann" supposed to be the "clean, sleek-looking logo that’s really bold"? I really can't find anything on their website that I would call a logo. The new brand, “Life more Humann” if that’s correct, is cool. Imagine having to account for every bite of food you eat, getting injected several times/day, poking the finger, and god forbid being a young kid. People living with diabetes live differently than us more fortunate, the ultra rapid action of Afrezza is a blessing to those who choose to take the time and effort to learn how to effectively use it. The re-branding reintroduces both Mannkind and Afrezza, the company needed to freshen things up in my opinion. Great article 😎 |
|
|
|
Post by ktim on Mar 4, 2020 21:03:23 GMT -5
I seem to be missing the point of the "rebranding." I mean, what purpose does "new lobby signage and personalized desk drops" serve? Ditto "employee giveaways — tote and jacket"? Is it just to boost employee morale? And is "humann" supposed to be the "clean, sleek-looking logo that’s really bold"? I really can't find anything on their website that I would call a logo. The new brand, “Life more Humann” if that’s correct, is cool. Imagine having to account for every bite of food you eat, getting injected several times/day, poking the finger, and god forbid being a young kid. People living with diabetes live differently than us more fortunate, the ultra rapid action of Afrezza is a blessing to those who choose to take the time and effort to learn how to effectively use it. The re-branding reintroduces both Mannkind and Afrezza, the company needed to freshen things up in my opinion. Great article 😎 So far neither of the Afrezza related websites use this new branding (inhalemyinsulin.com and afrezza.com). Has anyone seen someplace they are using this new branding to market Afrezza? Maybe the reps wear their jackets. |
|
